- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02743312
Long-Term Effects of Torso-Weighting (TWPS)
Long-Term Effects of Balance-Based Torso-Weighting: Pilot Study
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
Oakland, California, Estados Unidos, 94609
- Samuel Merritt University, Motion Analysis Research Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Self-reported a diagnosis of multiple sclerosis
- Self-reported mild or moderate gait or balance difficulties
- Living in the community rather than in a care facility
- Able to walk independently for at least one minute at a time with or without an assistive device
- No exacerbations within the past 2 months
- Able to get to the testing area and tolerate 2-3 hours of testing for each assessment occasion
- Willing to be nudged by a researcher when standing
Exclusion Criteria:
- Unable to comprehend and follow instructions in English
- Current diagnosis of other neurological disorders such as head injury, stroke, Parkinson disease, or other conditions that affect gait or balance (self-reported)
- Experiencing pain that could be exacerbated by external perturbation while standing
- History of skin reaction to adhesives
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Torso Weights then Sham Weights
No weights worn for 4 weeks. Garment with torso weights worn 2-4 hours daily for 2 weeks. Then participants cross-over to wear garment with sham weights for 2-4 hours daily for 2 weeks. Participants wear the Fitbit Flex throughout. |
Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.
Outros nomes:
Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.
The garment is then taken by another investigator and the actual weights are replaced with sham weights.
Outros nomes:
Potential effect on participants' physical activity to see their own step count using this wrist-worn remote monitoring device.
Outros nomes:
|
Experimental: Sham Weights then Torso Weights
No weights worn for 4 weeks. Garment with sham weights worn 2-4 hours daily for 2 weeks. Then participants cross-over to wear garment with torso weights for 2-4 hours daily for 2 weeks. Participants wear the Fitbit Flex throughout. |
Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.
Outros nomes:
Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.
The garment is then taken by another investigator and the actual weights are replaced with sham weights.
Outros nomes:
Potential effect on participants' physical activity to see their own step count using this wrist-worn remote monitoring device.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Steps Per Day
Prazo: up to 8 weeks
|
Continuous activity data collection via commercially-available remote monitoring device and stored on server.
|
up to 8 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Sensory Organization Test
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
balance tested during 6 conditions on Neuro-com forceplate and surround and reported as a composite score (across the six conditions), 0-100, with higher scores indicating better balance; measure reported reflects change in the composite score from the visit that initiates Torso-weighting (TW) or sham weights (SW) to the visit that concludes daily wearing of TW or SW
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Gait Velocity
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
As measured using instrumented gait mat.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Movement Ability Measure, Computer Adaptive Test Version (MAM-CAT)
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Online self-report of perceived current movement ability and preferred movement ability.
The scores are reported in standardized logits, 0-6, where 6 is competitive level athletic movement.
The reported values are the average change in current movement ability from initiation of daily wear to after 2 weeks of daily wear of TW or SW.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Activities-Specific Balance Confidence Scale
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Self-report measure of perception of confidence under various balance challenges on a scale of 0-100 with 100 being fully confident that the individual can perform the listed balance challenge without falling.
Data reported reflect the difference in scores from initiation to the 2-week point after initiation of TW or SW.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Multiple Sclerosis Impact Scale 29
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Self-report measure of the impact of MS on activities and participation.
The scale is reported in a physical and psychological subscale, with higher numbers (out of 100) indicating worse impact of multiple sclerosis (MS) on function.
Data are reported as change from initiation of TW or SW to end of 2 weeks of daily wear.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Multiple Sclerosis Walking Scale 12
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Self-report measure of the effect of MS on walking ability.
Larger numbers out of 100 mean that MS limits walking much more.
Data are reported as change in score from initiation of TW or SW to the visit after 2 weeks of daily wear of TW or SW.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Six-Minute Walk Test
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
distance participant walks in 6 minutes.
Larger numbers indicate more distance covered.
Data reported are the change in distance walked from initiation of TW or SW to after 2 weeks of daily wear.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Stride Length
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
As measured using instrumented gait mat.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Percent of Gait Cycle in Single Limb Support
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
As measured in percent (e.g., 0.35) of gait cycle spent on one limb using instrumented gait mat.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Step Width
Prazo: change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
As measured using instrumented gait mat.
|
change from initiation to 2-weeks after initiation of daily wearing of TW or SW
|
Electromyography to Assess Muscle Activation
Prazo: Week 4, Week 6, Week 8
|
Recording of muscle activation during quiet and perturbed standing before and after intervention at weeks 4, 6, and 8. Average values with and without weighting during each visit.
|
Week 4, Week 6, Week 8
|
Number of Falls Recorded in 2 Weeks of Wear Time.
Prazo: count of number of falls recorded at the end of two weeks of wearing TW or SW
|
Daily log manually recorded by participant for the 2 weeks of wear time.
This is a descriptive measure recording the total count (number) of falls per arm.
|
count of number of falls recorded at the end of two weeks of wearing TW or SW
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Diane Allen, PhD, San Francisco State University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- X15-48a
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Torso Weights
-
Centre Hospitalier Universitaire Dinant Godinne...RecrutamentoCarcinoma Espinocelular Supraglótico | Estágio inicial (T1-T2, N0-N1,M0)Bélgica
-
Abramson Cancer Center of the University of PennsylvaniaConcluídoCâncer de orofaringeEstados Unidos
-
University Hospital, GhentConcluído
-
Hospices Civils de LyonConcluídoCarcinoma Espinocelular SupraglóticoFrança
-
Rigshospitalet, DenmarkAtivo, não recrutandoQualidade de vida | Dor | Câncer de Orofaringe | Vírus do Papiloma Humano | Distúrbio de deglutição | Saliva alteradaDinamarca
-
University of PennsylvaniaConcluído
-
M.D. Anderson Cancer CenterRescindidoCâncer de orofaringeEstados Unidos
-
Wake Forest University Health SciencesConcluídoNeoplasias de Cabeça e PescoçoEstados Unidos
-
Mayo ClinicRecrutamentoCâncer de Cabeça e Pescoço | Neoplasias OrofaríngeasEstados Unidos
-
Ohio State University Comprehensive Cancer CenterRecrutamentoCâncer de língua | Carcinoma Espinocelular Recidivante de Hipofaringe | Carcinoma Espinocelular Recidivante de Laringe | Carcinoma Espinocelular Recidivante de Lábio e Cavidade Oral | Carcinoma Verrucoso Recorrente de Laringe | Carcinoma Verrucoso Recorrente da Cavidade Oral | Carcinoma Adenóide... e outras condiçõesEstados Unidos